The lowest of the four biosafety levels and is suitable for work involving well-characterized agents not known to consistently cause disease in healthy adult humans. These organisms pose minimal ...

BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...

ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf is proud to announce they have received Connecticut State approval to conduct Biosafety Level 2 (BL2) infectious disease related research. This greatly ...

When the COVID-19 pandemic arrived in the United States in 2020, the American research community experienced a sudden spike in funding. Universities, pharmaceutical companies, and state and federal ...

In Manhattan, Kan., the National Bio and Agro-Defense Facility (NBAF), an animal disease research facility, has finished construction. Replacing the 68-year-old Plum Island Animal Disease Center, NBAF ...

What do hantavirus, the Yersinia pestis bacteria, the 1918 influenzas virus, and the H5N1 virus have in common? The virus found in rodent droppings, the culprit behind the Black Death, the cause of ...

Vanderbilt University Medical Center has been awarded a nearly $8 million grant to construct a facility for research involving COVID-19, anthrax, tuberculosis and other dangerous microorganisms. The ...

If NIH prioritizes human-based science in its ongoing overhaul of biosafety policies, the oversight system that has evolved for review of a wide-swath of biological research could atrophy and expose ...

A former senior adviser to National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci shared “confidential” communications with EcoHealth Alliance about how the agency was ...

The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids (NIH Guidelines) provide details regarding "the practices for constructing and handling: (i) recombinant nucleic acid ...